Tirzepatide is a synthetic derivative of gastric inhibitory polypeptide (GIP) with glucagon-like peptide-1 (GLP-1) functionality, originally developed to study type 2 diabetes treatments. It has been shown to have potential benefits in lowering blood glucose levels, enhancing insulin sensitivity, promoting satiety, and accelerating weight loss. Additionally, Tirzepatide may offer cardiovascular protective effects. Bacteriostatic water, alcohol wipes, and syringes included.